These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3921404)

  • 1. A molecular mechanism for the biphasic effect of exogenous arachidonate on platelets.
    Jamaluddin MP; Krishnan LK
    FEBS Lett; 1985 Apr; 183(2):287-92. PubMed ID: 3921404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational responses of an arachidonate- and U46619-binding haemoprotein in relation to platelet activation.
    Krishnan LK; Jamaluddin MP
    FEBS Lett; 1987 Feb; 212(2):213-9. PubMed ID: 3102280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of human platelets exposed to arachidonate upon stimulation with other agonists: possible role of Ca2+i movement.
    Chen ZM; Cerletti C; de Gaetano G; Bertelé V
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1193-9. PubMed ID: 3122746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metabolized and unmetabolized arachidonate on rat platelet shape change.
    Lampugnani MG; de Gaetano G
    Am J Physiol; 1984 Sep; 247(3 Pt 2):H440-5. PubMed ID: 6433724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin.
    Mazurov AV; Leytin VL; Repin VS; Taube C; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S373-6. PubMed ID: 6440553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets, eicosanoids, and coronary vasospasm.
    Schrör K; Verheggen R
    Prog Clin Biol Res; 1987; 242():165-70. PubMed ID: 3118379
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes.
    Halushka PV; Boehm A; Mais DE
    Eicosanoids; 1988; 1(1):41-4. PubMed ID: 2856171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonate is an antagonist of platelet activation by the endoperoxide analog U46619.
    Huang EM; Detwiler TC
    Biochim Biophys Acta; 1982 Apr; 715(2):246-9. PubMed ID: 6803846
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
    Mazurov AB; Leĭtin VL; Repin VS
    Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of mesangial cell contraction by arachidonate metabolites.
    Mené P; Dunn MJ
    Trans Assoc Am Physicians; 1986; 99():125-31. PubMed ID: 3111059
    [No Abstract]   [Full Text] [Related]  

  • 16. Arachidonic acid-induced calcium influx in human platelets. Comparison with the effect of thrombin.
    Alonso MT; Sanchez A; Garcia-Sancho J
    Biochem J; 1990 Dec; 272(2):435-43. PubMed ID: 2125206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
    Hornberger W; Patscheke H
    Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor.
    Oglesby TD; Gorman RR
    Biochim Biophys Acta; 1984 Apr; 793(2):269-77. PubMed ID: 6424715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
    Rump LC; Schollmeyer P
    Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
    Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
    Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.